Post-approval studies (Phase 4)Study completedNCT00216515
What this trial is testing
The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
Who this might be right for
Alzheimer Disease
Janssen Korea, Ltd., Korea 102